Ten Years of Denosumab Treatment in Postmenopausal Women With Osteoporosis: Results from the FREEDOM Extension Trial

被引：0

作者：

Bone, Henry ^{[1
]}

Brandi, Maria-Luisa ^{[2
]}

Brown, Jacques ^{[3
]}

Chapurlat, Roland ^{[4
]}

Cummings, Stephen ^{[5
]}

Czerwinski, Edward ^{[6
]}

Fahrleitner-Pamer, Astrid ^{[7
]}

Kendler, David ^{[8
]}

Lippinur, Kurt ^{[9
]}

Reginster, Jean-Yves ^{[10
]}

Vittinghoff, Eric ^{[11
]}

Daizadeh, Nadia ^{[12
]}

Wang, Andrea ^{[12
]}

Dakin, Paula ^{[12
]}

Wagman, Rachel ^{[12
]}

Papapoulos, Socrates ^{[13
]}

机构：

[1] Michigan Bone & Mineral Clin, Detroit, MI USA

[2] Univ Florence, Azienda Osped Careggi, I-50121 Florence, Italy

[3] CHU Quebec, Quebec City, PQ, Canada

[4] Hop Edouard Herriot, Lyon, France

[5] San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA USA

[6] Krakow Med Ctr, Krakow, Poland

[7] Med Univ Graz, Graz, Austria

[8] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[9] Univ Hosp Bern, Bern, Switzerland

[10] Univ Liege, Liege, Belgium

[11] UCSF, San Francisco, CA USA

[12] Amgen Inc, Thousand Oaks, CA 91320 USA

[13] Leiden Univ, Med Ctr, Leiden, Netherlands

来源：

JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

151

引用

页码：1209 / 1209

页数：1

共 50 条

[41] HIGH LEVEL OF ENGAGEMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE TREATMENT WITH DENOSUMAB
Solakov, P.
Kuzmanova, S.
OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S239 - S239
[42] TREATMENT PERSISTENCE IN SWEDISH WOMEN INITIATING DENOSUMAB TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS
Karlsson, L.
Lundkvist, J.
Intorcia, M.
Psachoulia, E.
Strom, O.
VALUE IN HEALTH, 2013, 16 (07) : A567 - A567
[43] EFFECTS OF UP TO 10 YEARS OF DENOSUMAB TREATMENT ON BONE MATRIX MINERALIZATION: RESULTS FROM THE FREEDOM EXTENSION (EXT)
Dempster, D. W.
Brown, J. P.
Yue, S.
Rizzo, S.
Farlay, D.
Wagman, R. B.
Wang, A.
Yin, X.
Boivin, G.
OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S177 - S177
[44] Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
T. Sugimoto
T. Matsumoto
T. Hosoi
T. Miki
I. Gorai
H. Yoshikawa
Y. Tanaka
S. Tanaka
M. Fukunaga
T. Sone
T. Nakano
M. Ito
S. Matsui
T. Yoneda
H. Takami
K. Watanabe
T. Osakabe
N. Okubo
M. Shiraki
T. Nakamura
Osteoporosis International, 2015, 26 : 765 - 774
[45] A Phase III Study of the Effects of Denosumab on Vertebral, Nonvertebral, and Hip Fracture in Women with Osteoporosis: Results from the FREEDOM Trial
Cummings, S. R.
McClung, M. R.
Christiansen, C.
Siris, E.
Adami, S.
Kutilek, S.
Reid, I. R.
Zanchetta, J. R.
Martin, J. San
Libanati, C.
Siddhanti, S.
Wang, A.
Delmas, P. D.
JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S80 - S80
[46] Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
Sugimoto, T.
Matsumoto, T.
Hosoi, T.
Miki, T.
Gorai, I.
Yoshikawa, H.
Tanaka, Y.
Tanaka, S.
Fukunaga, M.
Sone, T.
Nakano, T.
Ito, M.
Matsui, S.
Yoneda, T.
Takami, H.
Watanabe, K.
Osakabe, T.
Okubo, N.
Shiraki, M.
Nakamura, T.
OSTEOPOROSIS INTERNATIONAL, 2015, 26 (02) : 765 - 774
[47] Denosumab - an emerging treatment for postmenopausal osteoporosis
Lewiecki, E. Michael
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 467 - 476
[48] Denosumab in the Treatment of Postmenopausal Osteoporosis: A Review
Handique, C.
Lahkar, M.
Bordoloi, P.
INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S106 - S106
[49] Denosumab (Prolia) for Treatment of Postmenopausal Osteoporosis
Johnson, Gretchen L.
AMERICAN FAMILY PHYSICIAN, 2012, 85 (04) : 334 - +
[50] The Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis
Aras, Berke
Kuzu, Omer
ERCIYES MEDICAL JOURNAL, 2022, 44 (03) : 312 - 317

← 1 2 3 4 5 →